{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:05:37Z","timestamp":1792249537160,"version":"4.4.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>We evaluated an elvitegravir\u2013cobicistat\u2013emtricitabine\u2013tenofovir alafenamide single-tablet regimen for human immunodeficiency virus postexposure prophylaxis. The completion rate and adherence were good, and the tolerance was acceptable; no seroconversion was observed. We confirm that this regimen could be appropriate for postexposure prophylaxis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Trials Registration<\/jats:title>\n                  <jats:p>NCT02998320.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz577","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T11:09:08Z","timestamp":1561633748000},"page":"943-946","source":"Crossref","is-referenced-by-count":9,"title":["Elvitegravir\u2013Cobicistat\u2013Emtricitabine\u2013Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis"],"prefix":"10.1093","volume":"70","author":[{"given":"Pierre","family":"Gantner","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Virology, H\u00f4pitaux Universitaires de Strasbourg , Rennes,","place":["France"]},{"name":"INSERM, Strasbourg University, H\u00f4pital Saint Andr\u00e9, Centre Hospitalier Universitaire de Bordeaux , Rennes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Hessamfar","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, H\u00f4pital Saint Andr\u00e9, Centre Hospitalier Universitaire de Bordeaux , Rennes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Faouzi","family":"Souala","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire Pontchaillou , Rennes,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Valin","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses et Tropicales, H\u00f4pital Saint-Antoine, Assistance Publique\u2013H\u00f4pitaux de Paris (APHP) , APHP,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Simon","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , APHP,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Ajana","sequence":"additional","affiliation":[{"name":"Service Universitaire des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing , APHP,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bouvet","sequence":"additional","affiliation":[{"name":"Service de Maladies Infectieuses, H\u00f4pital Bichat , APHP,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Rouveix","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital Ambroise Par\u00e9 , APHP,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Cotte","sequence":"additional","affiliation":[{"name":"Maladies Infectieuses et Tropicales, H\u00f4pital de la Croix Rousse , Lyon,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouz\u00e9","family":"Bani-Sadr","sequence":"additional","affiliation":[{"name":"Unit\u00e9 des Maladies Infectieuses et Tropicales, H\u00f4pital Robert Debr\u00e9 , Reims,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Hustache-Mathieu","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, H\u00f4pital Jean Minjoz , Besan\u00e7on,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Gis\u00e8le","family":"Lebrette","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, H\u00f4pital Tenon , APHP, Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Truchetet","sequence":"additional","affiliation":[{"name":"Service de Dermatologie, Centre Hospitalier Metz-Thionville , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Galempoix","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Infectieuse, Centre Hospitalier Manchester , Charleville-M\u00e9zi\u00e8res, Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Piroth","sequence":"additional","affiliation":[{"name":"D\u00e9partement d\u2019Infectiologie, Centre Hospitalier Universitaire de Dijon , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Pellissier","sequence":"additional","affiliation":[{"name":"Groupe d\u2019\u00e9tude sur le Risque d\u2019exposition des Soignants aux Agents Infectieux , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Muret","sequence":"additional","affiliation":[{"name":"Laboratoire de pharmacologie clinique, INSERM, H\u00f4pital Jean Minjoz , Besan\u00e7on,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rey","sequence":"additional","affiliation":[{"name":"Le Trait d\u2019Union, HIV-Infection Care Center, H\u00f4pitaux Universitaires de Strasbourg ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"E\/C\/F\/TAF PEP Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"2024111411411658800_CIT0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10461-013-0567-0","article-title":"Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis","volume":"18","author":"Oldenburg","year":"2014","journal-title":"AIDS Behav"},{"key":"2024111411411658800_CIT0002","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1097\/QAD.0000000000000505","article-title":"Adherence to HIV postexposure prophylaxis: a systematic review and meta-analysis","volume":"28","author":"Ford","year":"2014","journal-title":"AIDS"},{"key":"2024111411411658800_CIT0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jinf.2017.10.008","article-title":"Adherence to HIV post-exposure prophylaxis: a multivariate regression analysis of a 5 years prospective cohort","volume":"76","author":"Malinverni","year":"2018","journal-title":"J Infect"},{"key":"2024111411411658800_CIT0004","doi-asserted-by":"crossref","first-page":"e0142534","DOI":"10.1371\/journal.pone.0142534","article-title":"Adherence to post-exposure prophylaxis (PEP) and Incidence of HIV seroconversion in a Major North American cohort","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"key":"2024111411411658800_CIT0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cid\/civ511","article-title":"Single-tablet emtricitabine-rilpivirine-tenofovir as HIV postexposure prophylaxis in men who have sex with men","volume":"61","author":"Foster","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2024111411411658800_CIT0006","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1093\/jac\/dkx246","article-title":"Tenofovir disoproxil fumarate\/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis","volume":"72","author":"Inciarte","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2024111411411658800_CIT0007","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QAI.0000000000001440","article-title":"Optimal HIV postexposure prophylaxis regimen completion with single tablet daily elvitegravir\/cobicistat\/tenofovir disoproxil fumarate\/emtricitabine compared with more frequent dosing regimens","volume":"75","author":"Mayer","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024111411411658800_CIT0008","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12879-016-2056-3","article-title":"Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis","volume":"16","author":"Valin","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2024111411411658800_CIT0009","author":"Groupe d\u2019Experts Pour la Prise en Charge du VIH"},{"key":"2024111411411658800_CIT0010","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"2024111411411658800_CIT0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40262-016-0424-1","article-title":"Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors","volume":"56","author":"Podany","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"2024111411411658800_CIT0012","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.3390\/ijerph110302804","article-title":"Health-related quality of life and utility scores in people with mental disorders: a comparison with the non-mentally ill general population","volume":"11","author":"Prigent","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"2024111411411658800_CIT0013","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/QAD.0000000000001447","article-title":"Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men","volume":"31","author":"McAllister","year":"2017","journal-title":"AIDS"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz577\/28984573\/ciz577.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/5\/943\/32450041\/ciz577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/70\/5\/943\/32450041\/ciz577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:31:01Z","timestamp":1731587461000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/5\/943\/5525174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,6,28]]},"published-print":{"date-parts":[[2020,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz577","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,1]]},"published":{"date-parts":[[2019,6,28]]}}}